Connect Biopharma Holdings earnings were -$64.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest CNTB earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$19.4M, up 28.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CNTB reported annual earnings of -$55.5M, with 255% growth. The next CNTB earnings date is Aug 12, 2026.
Connect Biopharma Holdings Earnings Reports & History FAQ
What were Connect Biopharma Holdings's earnings last quarter?
Connect Biopharma Holdings (NASDAQ: CNTB) reported Q1 2026 earnings per share (EPS) of -$0.34, up 78.95% year over year. Total CNTB earnings for the quarter were -$19.40 million. In the same quarter last year, Connect Biopharma Holdings's earnings per share (EPS) was -$0.19.
When does Connect Biopharma Holdings report earnings?
The next CNTB earnings date is Aug 12, 2026. Add CNTB to your watchlist to be reminded of Connect Biopharma Holdings's next earnings date.
Is Connect Biopharma Holdings profitable or losing money?
As of the last Connect Biopharma Holdings earnings report, Connect Biopharma Holdings is currently losing money. Connect Biopharma Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$64.61 million, a 275.46% increase year over year.
What was CNTB's earnings growth in the past year?
As of Connect Biopharma Holdings's earnings date in Q3 2026, Connect Biopharma Holdings's earnings has grown year over year. CNTB earnings in the past year totalled -$64.61 million.
What are Connect Biopharma Holdings's earnings expectations?
The current EPS estimate for Connect Biopharma Holdings's earnings report in Aug 12, 2026 is -$0.34.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.